Immediate Impact
1 from Science/Nature 90 standout
Citing Papers
Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
2025 Standout
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Works of Minodora Mazur being referenced
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)
2016
OP0263 Efficacy and safety of GLPG0634, a selective JAK1 inhibitor, after short-term treatment of rheumatoid arthritis; results of a phase IIA trial
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Minodora Mazur | 267 | 51 | 89 | 135 | 108 | 19 | 354 | |
| Irina Lazariciu | 214 | 32 | 52 | 78 | 71 | 13 | 325 | |
| D. Schlichting | 198 | 39 | 63 | 118 | 155 | 27 | 357 | |
| Tiina M. Järvinen | 118 | 52 | 78 | 83 | 154 | 14 | 376 | |
| E. Keystone | 247 | 67 | 53 | 33 | 81 | 25 | 340 | |
| Gabriel Medrano-Ramírez | 140 | 59 | 92 | 47 | 157 | 12 | 345 | |
| Panagiotis Garantziotis | 219 | 45 | 32 | 43 | 206 | 25 | 363 | |
| Lucyna Korman | 199 | 65 | 18 | 60 | 156 | 27 | 382 | |
| Beatriz Rodríguez‐Bayona | 109 | 27 | 75 | 56 | 220 | 15 | 368 | |
| Nikolay Delev | 275 | 21 | 26 | 67 | 227 | 24 | 381 | |
| Gloria Lliso-Ribera | 276 | 23 | 24 | 43 | 135 | 12 | 385 |
All Works
Login with ORCID to disown or claim papers
Loading papers...